SLC6A4 and inflammatory bowel disease: Our results highlight critical differences in mouse, rat and human physiology, and we showed that hiPS cell-derived organoids serve as a relevant model for future translational research focused on the effects of serotonin agonists and SERT inhibitors on alleviating intestinal inflammation in patients with IBD.